Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab. (2021). Archives of Clinical and Biomedical Research, 5(6), 972-982. https://www.fortunejournals.org/ojs/index.php/acbr/article/view/14882